Synergistic activation of PKD by the B cell antigen receptor and CD19 requires PI3K, Vav1 and PLCγ

被引:9
作者
Vigorito, Elena [1 ]
Kovesdi, Dorottya [1 ]
Turner, Martin [1 ]
机构
[1] Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge CB2 4AT, England
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
B cells; BCR; signalling; Vav; PKD;
D O I
10.1016/j.cellsig.2005.11.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Antigens coated with complement fragments coligate the B cell receptor (13CR) with the CD21/CD19 complex which results in synergistic activation of B cells. Previous studies identified PI3K, Vav proteins and PLC-gamma as important components of this synergy. We now show that protein kinase D (also known as PKC mu) is also a point of convergence of these signalling pathways. We found that PKD activation upon BCR engagement or coligation of the BCR with CD19 is entirely dependent on PI3K and PLC-gamma but differ in the requirement for Vav proteins. Whereas PKD activation is Vav1 and Vav2 dependent in response to BCR cross-linking, PKD activation is sensitive to the lack of Vav1 under synergistic stimulation of BCR and CD19. These findings show that Vav proteins and PI3K regulation of PLC-gamma contributes to the activation of PKD in response to BCR and or CD19 cross-linking. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1455 / 1460
页数:6
相关论文
共 38 条
[1]   Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1 [J].
Arnold, R ;
Patzak, IM ;
Neuhaus, B ;
Vancauwenbergh, S ;
Veillette, A ;
Van Lint, J ;
Kiefer, F .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (06) :2364-2383
[2]   PLCγ2 regulates Bcl-2 levels and is required for survival rather than differentiation of marginal zone and follicular B cells [J].
Bell, SE ;
Vigorito, E ;
McAdam, S ;
Reynolds, HM ;
Caraux, A ;
Colucci, F ;
Turner, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (08) :2237-2247
[3]   The two NF-κB activation pathways and their role in innate and adaptive immunity [J].
Bonizzi, G ;
Karin, M .
TRENDS IN IMMUNOLOGY, 2004, 25 (06) :280-288
[4]   Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: Clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines [J].
Brooks, SR ;
Li, XL ;
Volanakis, EJ ;
Carter, RH .
JOURNAL OF IMMUNOLOGY, 2000, 164 (06) :3123-3131
[5]  
CARTER RH, 1991, J IMMUNOL, V147, P3663
[6]   BLNK:: molecular scaffolding through 'cis'-mediated organization of signaling proteins [J].
Chiu, CW ;
Dalton, M ;
Ishiai, M ;
Kurosaki, T ;
Chan, AC .
EMBO JOURNAL, 2002, 21 (23) :6461-6472
[7]   Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product [J].
Crespo, P ;
Schuebel, KE ;
Ostrom, AA ;
Gutkind, JS ;
Bustelo, XR .
NATURE, 1997, 385 (6612) :169-172
[8]   Vav and the B cell signalosome [J].
DeFranco, AL .
NATURE IMMUNOLOGY, 2001, 2 (06) :482-484
[9]   Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis [J].
Dequiedt, F ;
Van Lint, J ;
Lecomte, E ;
Van Duppen, V ;
Seufferlein, T ;
Vandenheede, JR ;
Wattiez, R ;
Kettmann, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :793-804
[10]   Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes [J].
Doody, GM ;
Billadeau, DD ;
Clayton, E ;
Hutchings, A ;
Berland, R ;
McAdam, S ;
Leibson, PJ ;
Turner, M .
EMBO JOURNAL, 2000, 19 (22) :6173-6184